Dr. Scott R. Curry, M.D.
Infectious Disease (Infectious Disease Physician)
- Medicare participating
At a glance
- Medical school
- Medical University of South Carolina College of Medicine (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 144
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: Medical University of South Carolina College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Infectious Disease Physician primary
SC license 39371 · PA license MD433588
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Musc Medical Center Charleston, SC
- Tidelands Waccamaw Community Hospital Murrells Inlet, SC
- Musc Health Florence Medical Center Florence, SC
Medical groups
- University Medical Associates of the Medical University of South Carol (1,668 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 144
- Services billed
- 320
- Patients’ average age
- 68
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 127 | 58 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 48 | 48 |
| Established patient office or other outpatient visit, 30-39 minutes | 25 | 19 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 16 | 16 |
| New patient office or other outpatient visit, 60-74 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Biktarvy (bictegrav/emtricit/tenofov ala) | 53 |
| Amlodipine Besylate Other prescribers in Charleston, SC | 50 |
| Cefazolin Sodium | 26 |
| Ceftriaxone (ceftriaxone sodium) Other prescribers in Charleston, SC | 24 |
| Vancomycin Hcl | 22 |
| Cabenuva (cabotegravir/rilpivirine) | 19 |
| Ciprofloxacin Hcl Other prescribers in Charleston, SC | 19 |
| Sertraline Hcl Other prescribers in Charleston, SC | 18 |
| Prezcobix (darunavir/cobicistat) | 18 |
| Tivicay (dolutegravir sodium) | 16 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $5,360 in research payments for these studies, mostly to the institutions running them.
- An Observational Study in Adults with Clostridioides difficile Infection to Determine the Feasibility and Logistics of Biospecimen Collection Transportation and Testing at Select US Study Sites
AstraZeneca Pharmaceuticals LP - REBYOTA™ Prospective Registry
Ferring Pharmaceuticals As · Completed · NCT05835219
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.